They have a pipeline that includes biosimilars, small molecules, and bispecific mAbs for oncology, inflammatory/neurodegenerative diseases, and other conditions.
Contact Details | Office: 64, Cheonho-daero, Dongdaemun-gu, Seoul Phone call: 02-920-8111 |
---|